Docetaxel and anthracycline polychemotherapy in the treatment of breast cancer

被引：0
|
作者：
Nabholtz, JM [1 ]
Smylie, M [1 ]
Mackey, J [1 ]
Au, HJ [1 ]
Tonkin, K [1 ]
Au, R [1 ]
Morrish, D [1 ]
Salter, E [1 ]
机构：
[1] Cross Canc Inst, No Alberta Breast Canc Program, Edmonton, AB T6G 1Z2, Canada
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：47 / 52
页数：6
相关论文
共 50 条
  • [21] Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer
    Brodowicz, T
    Koestler, WJ
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (03) : 149 - 153
  • [22] Weekly docetaxel as second-line therapy for patients with advanced breast cancer resistant to previous anthracycline treatment
    Ramos, M
    González-Ageitos, A
    Amenedo, M
    González-Quintas, A
    Gamazo, JL
    Togores, P
    Losada, G
    Almanza, C
    Romero, C
    Gómez-Martín, C
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (02) : 192 - 197
  • [23] Anthracycline Cardiotoxicity After Breast Cancer Treatment
    Hershman, Dawn L.
    Shao, Theresa
    ONCOLOGY-NEW YORK, 2009, 23 (03): : 227 - 234
  • [24] EXPERIENCES WITH PAC-POLYCHEMOTHERAPY OR PEC-POLYCHEMOTHERAPY IN TREATMENT OF PROGREDIENT OF RECURRENT BREAST-CANCER
    WERNER, A
    HEUER, J
    SCHULZ, BO
    DIEDRICH, K
    OBERHEUSER, F
    KREBS, D
    ZENTRALBLATT FUR GYNAKOLOGIE, 1988, 110 (10): : 603 - 610
  • [25] A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy
    C. G. Alexopoulos
    G. Rigatos
    A. P. Efremidis
    A. Papacharalambous
    A. Alexopoulos
    M. Vassilomanolakis
    E. Patila
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 253 - 258
  • [26] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [27] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PHTHJ
    Jong, PC
    Jong, RS
    Honkoop, AH
    Coenen, JLLM
    Rodenburg, CJ
    Rooda, SJE
    Douma, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
  • [28] Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer
    Moon, Y. W.
    Kim, J. H.
    Choi, H. J.
    Park, B. W.
    Kim, S. I.
    Park, S. H.
    Koo, J. S.
    Cho, J. Y.
    Kim, Y. T.
    Sohn, J. H.
    EJC SUPPLEMENTS, 2009, 7 (02): : 279 - 279
  • [29] Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer
    Georgoulias, VA
    ONCOLOGY-NEW YORK, 2001, 15 (02): : 18 - 24
  • [30] Polychemotherapy for early breast cancer - Reply
    Cole, BF
    Gelber, RD
    Gelber, S
    Coates, AS
    Goldhirsch, A
    LANCET, 2001, 358 (9299): : 2170 - 2170
12345